{
    "relation": [
        [
            "References",
            "Ferreux et al. [105]",
            "Poetsch et al. [112]",
            "Soufir et al. [106]",
            "Guerreto et al. [108]",
            "Yanagawa et al. [109]",
            "Yanagawa et al. [110]",
            "Kalantari et al. [107]",
            "Rogenhofer et al. [111]"
        ],
        [
            "Number of samples",
            "53",
            "52",
            "3",
            "24",
            "26",
            "25",
            "24",
            "65"
        ],
        [
            "Method",
            "Methylation-specific PCR",
            "Methylation-specific PCR",
            "Methylation-specific PCR",
            "Methylation-specific PCR",
            "Methylation-specific PCR",
            "Methylation-specific PCR",
            "DNA sequencing",
            "Immunohistochemical"
        ],
        [
            "Gene studied",
            "CDKN2A",
            "CDKN2A",
            "CDKN2A",
            "CDKN2A RASSF1A TSP-1",
            "DAPK FHIT MGMT CDKN2A (p16INK4A) CDKN2A (p14ARF) RAR\u03b2 RASSF1A RUNX3",
            "DAPK FHIT MGMT CDKN2A (p16INK4A) CDKN2A (p14ARF) RAR\u03b2 RASSF1A RUNX3",
            "L1 HPV16 LCR HPV16",
            "H3K4 H3K9 H3K27"
        ],
        [
            "% methylation",
            "9 (17%)",
            "22 (42%)",
            "0 (0%)",
            "9 (38%) 10 (42%) 11 (46%)",
            "7 (26.9%) 23 (88.4%) 5 (19.2%) 1 (3.8%) 6 (23.1%) 6 (23.1%) 3 (11.5%) 11 (42.3%)",
            "7 (28%) 23 (92%) 5(20%) 1 (4%) 6 (24%) 6 (24%) 3 (12%) 11 (44%)",
            "58% 22%",
            "H3K4me1 Decrease H3K9me1 Decrease H3K9me2 Decrease H3K27me2 Decrease H3K27me3 Decrease H3K9me3 Increase"
        ],
        [
            "HPV infection",
            "20 (38%)",
            "20 (38%)",
            "2 (66.3%)",
            "11 (46%)",
            "3 (11.5%)",
            "3 (12%)",
            "24 (100%)",
            ""
        ],
        [
            "HPV 16",
            "15 (28%)",
            "18 (35%)",
            "2 (100%)",
            "10 (42%)",
            "3 (11.5%)",
            "3 (12%)",
            "19 (79%)",
            ""
        ]
    ],
    "pageTitle": "IJMS | Free Full-Text | Epigenetic Mechanisms in Penile Carcinoma | HTML",
    "title": "Table 1. Summary of the epigenetics studies in penile carcinomas described in the literature.",
    "url": "http://www.mdpi.com/1422-0067/14/6/10791/htm",
    "hasHeader": true,
    "headerPosition": "FIRST_ROW",
    "tableType": "RELATION",
    "tableNum": 4,
    "s3Link": "common-crawl/crawl-data/CC-MAIN-2015-32/segments/1438042989443.69/warc/CC-MAIN-20150728002309-00115-ip-10-236-191-2.ec2.internal.warc.gz",
    "recordEndOffset": 577156311,
    "recordOffset": 577110237,
    "tableOrientation": "HORIZONTAL",
    "TableContextTimeStampAfterTable": "{60600=The authors would like to thank the National Council of Technological and Scientific Development (CNPq), Coordination for the Improvement of Higher Level Personnel (CAPES) and Funda\u00e7\u00e3o de Amparo a Pesquisa do Estado de S\u00e3o Paulo (FAPESP: 2010/51601-6 and 2009/52088-3). Authors would like to thank Cl\u00e1udia A. Rainho for her critical review and support with the figures., 18058=Int. J. Mol. Sci. 2013, 14(6), 10791-10808; doi:10.3390/ijms140610791, 159511=\u00a9 2013 by the authors; licensee MDPI, Basel, Switzerland This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution license ( http://creativecommons.org/licenses/by/3.0/).}",
    "textBeforeTable": "Table 1. Summary of the epigenetics studies in penile carcinomas described in the literature. Click here to display table CDKN2ARUNX3TSP-1RASSF1ARAR\u03b2CDKN2AMGMTFHITDAPKFigure 2. Click here to enlarge figure CDKN2ARUNX3TSP-1RASSF1ARAR\u03b2CDKN2AMGMTFHITDAPKFigure 2. 112108106CDKN2A gene was evaluated in six studies. and alteration in the expression levels of histones were events related with this disease. In special, , and , , , , , , Epigenetic alterations were described in eight studies of penile carcinoma (PeCa). Aberrant DNA methylation pattern of gene was evaluated in six studies. and alteration in the expression levels of histones were events related with this disease. In special, , and , , , , , , Epigenetic alterations were described in eight studies of penile carcinoma (PeCa). Aberrant DNA methylation pattern of ]. , , gene. Three studies evaluated the same CpG island in an amplicon",
    "textAfterTable": "\u00a9 2013 by the authors; licensee MDPI, Basel, Switzerland This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution license ( http://creativecommons.org/licenses/by/3.0/). Int. J. Mol. Sci. EISSN 1422-0067 Published by MDPI AG, Basel, Switzerland RSS E-Mail Table of Contents Alert Terms & Conditions Privacy Policy Contact MDPI Jobs at MDPI \u00a9 1996-2015 MDPI AG (Basel, Switzerland) unless otherwise stated",
    "hasKeyColumn": true,
    "keyColumnIndex": 3,
    "headerRowIndex": 0
}